29.10.2014 • News

BASF to Lift Chinese Tertiary Butylamine Output

BASF has announced it will expand output capability of its world-scale production plant for tertiary Butylamine (tBA) at the Nanjing Chemical Industry Park in China by 60%.

Under the plan, capacity will rise from 10,000 t/y at present to 16,000 t/y by 2015, provided regulatory authorities approve.

BASF said the additional capability for the primary aliphatic amine used as an intermediate in production of accelerators for the rubber and tire industry as well as a building block for pharmaceuticals and agrochemicals will "further strengthen" its leading position as a global supplier to the rubber and tire industry.

"The expansion will enable us to continue meeting the notably increased demand of our customers in Asia, especially China, reliably out of our local assets in China," said Guido Voit, senior vice president, BASF Intermediates Asia Pacific.

In addition to Nanjing, BASF produces tBA in Geismar, Louisiana, and in Antwerp, Belgium.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.